Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
620.00    0.00 (0.00%)
Bid:
619.50
Ask:
620.50
Spread: 1.00 (0.161%)
Market Cap: £2.87b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

AGM Update

17 Jul 2025 07:00

RNS Number : 3823R
RS Group PLC
17 July 2025
 

 

17 July 2025, 7.00 am

 

RS GROUP PLC

 

AGM update

 

Full year outlook unchanged

RS Group plc, the global product and service solutions provider for industrial customers, provides the following update ahead of its Annual General Meeting to be held at 12.00 pm today.

The Group continues to make good operational progress and our full year outlook is unchanged.

In the first quarter to 30 June 2025, trading in EMEA continued to reflect softer PMIs1, with underlying performance in Americas and Asia Pacific proving more resilient. We continued to deliver our strategic action plan including two significant projects of upgrading our digital platform in Americas and consolidating a Distrelec distribution centre in EMEA. Group like-for-like revenue2 decreased by 2% compared to the same period last year; excluding an anticipated and temporary impact of these operational improvements, trading was broadly flat.

We continue to invest to strengthen our proposition, drive ongoing market share growth and improve operational efficiency whilst remaining agile in our execution, pricing and cost management. We are confident that this will generate sustainable value and stronger returns as markets recover, in line with our medium-term financial targets. 

 

Notes:

1. Purchasing manager index (PMI) is a survey-based economic indicator designed to provide a timely insight into business conditions. The PMI is widely used to anticipate changing economic trends in official data such as GDP, or sometimes as an alternative gauge of economic performance and business conditions to official data, as the latter sometimes suffer from delays in publication, poor availability or data quality issues (Source: S&P Global).

2. Group like-for-like revenue excludes the impacts of acquisitions, foreign currency and trading days.

3. Company compiled consensus for the year ended 31 March 2026 has revenue of £2,937 million, adjusted operating profit of £269 million and adjusted profit before tax of £245 million. Source: rsgroup.com/investors/analyst-consensus/.

4. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2025 for euro and US dollar respectively were €1.189 and $1.276 respectively. Every 1 cent movement in the euro is forecast to have a c. £1.7 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar is forecast to have a c. £0.5 million impact on annual adjusted profit before tax.  

5. We expect to see a negative impact of around £9 million on revenue from fewer trading days in full year 2025/26 compared to 2024/25.  

 

Enquiries:

Kate Ringrose

Chief Financial Officer

020 7239 8400

Lucy Sharma

Martyn Espley

VP Investor Relations

Interim Head of Investor Relations

020 7239 8427

020 7239 8427

Martin Robinson

Teneo Communications

020 7260 2700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFWFWMEISESW
Date   Source Headline
3rd Jul 20238:00 amRNSCompletion of Distrelec Acquisition
30th Jun 202312:09 pmRNSNotice of Trading Update
20th Jun 202312:00 pmRNSDirector/PDMR Shareholding
15th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20239:00 amRNSHolding(s) in Company
7th Jun 202312:00 pmRNSAnnual Financial Report
1st Jun 20239:25 amRNSTotal Voting Rights
30th May 202312:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
26th May 202310:00 amRNSDirector/PDMR Shareholding
24th May 20238:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSFinal Results
15th May 202310:00 amRNSBoard Committee Change
3rd May 20237:00 amRNSDirectorate Change
2nd May 202310:00 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSAcquisition
13th Apr 20233:43 pmRNSHolding(s) in Company
5th Apr 20237:00 amRNSQ4 Trading Statement
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20239:00 amRNSChange of Auditor
21st Mar 20239:00 amRNSBlock Listing Application
17th Mar 20234:08 pmRNSNotice of Trading Update: Change of Date
14th Mar 20231:42 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSAppointment of Simon Pryce as CEO
9th Mar 20238:00 amRNSNotice of Trading Update
1st Mar 202312:19 pmRNSTotal Voting Rights
10th Feb 20234:20 pmRNSHolding(s) in Company
1st Feb 20238:51 amRNSBlock listing Interim Review
1st Feb 20238:45 amRNSTotal Voting Rights
26th Jan 20233:00 pmRNSAdditional Listing
13th Jan 20239:00 amRNS2022 AGM Vote Outcome Update Statement
10th Jan 20237:00 amRNSTrading Statement
9th Jan 20234:30 pmRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSCompletion of Risoul Acquisition
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 20229:13 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSDirectorate Change
1st Dec 20224:54 pmRNSTotal Voting Rights
7th Nov 20227:13 amRNSDirector Declaration
3rd Nov 20227:01 amRNSHalf-year Report
3rd Nov 20227:00 amRNSCEO Leave of Absence
1st Nov 202210:54 amRNSTotal Voting Rights
6th Oct 20227:00 amRNSTrading Statement
3rd Oct 202211:00 amRNSTotal Voting Rights
28th Sep 20221:41 pmRNSNotice of Trading Update
21st Sep 202211:00 amRNSHolding(s) in Company
1st Sep 20224:02 pmRNSAppointment of Joint Corporate Broker
1st Sep 202212:05 pmRNSTotal Voting Rights
17th Aug 202211:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.